{
  "id": 13935488,
  "title": "Biogen is set for big gains on slate of trial data releases, JPMorgan says",
  "url": "https://urgent.news/2026/10/12/biogen-is-set-for-big-gains-on-slate-of-trial-data-releases-jpmorgan",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-12T10:40:57.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/10/12/biogen-is-set-to-rally-on-slate-of-trial-data-releases-jpmorgan-says.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "Biogen upgraded at JPMorgan with $300 PT on 2027 pipeline catalysts, shares rise",
        "url": "https://urgent.news/2026/10/12/biogen-upgraded-at-jpmorgan-with-300-pt-on-2027-pipeline-catalysts",
        "published": "2026-10-12T08:59:12.000Z"
      },
      {
        "outlet": "CNBC World",
        "title": "Biogen is set for big gains on slate of trial data releases, JPMorgan says",
        "url": "https://urgent.news/2026/10/12/biogen-is-set-for-big-gains-on-slate-of-trial-data-releases-jpmorgan-13935531",
        "published": "2026-10-12T10:40:57.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}